TAVI Is a Reasonable Option for High-Risk Elderly Patients

Transcatheter aortic valve implantation benefits patients with severe symptomatic aortic stenosis

THURSDAY, May 3 (HealthDay News) -- For high-risk elderly patients with aortic stenosis, transcatheter aortic-valve implantation (TAVI) is a reasonable option, according to a study published in the May 3 issue of the New England Journal of Medicine.

Martine Gilard, M.D., Ph.D., from the Centre Hospitalier Universitaire Brest in France, and colleagues reported the results of a prospective multicenter study involving 3,195 elderly patients (mean age, 82.7 years) who underwent TAVI in France between January 2010 and October 2011. All participants were highly symptomatic and had a high surgical risk for aortic-valve replacement.

The investigators note that Edwards SAPIEN devices were implanted into 66.9 percent of patients and Medtronic CoreValve devices in 33.1 percent; they observed a success rate of 96.9 percent for the procedure. The approaches were transapical (17.8 percent), or transarterial (transfemoral, 74.6 percent; subclavian, 5.8 percent; or other, 1.8 percent). The rates of 30-day and one-year mortality were 9.7 and 24 percent, respectively. The incidence of stroke and periprosthetic aortic regurgitation at one-year was 4.1 and 64.5 percent, respectively. A higher logistic risk score on the European System for Cardiac Operative Risk Evaluation, New York Heart Association functional class III or IV symptoms, a transapical approach, and a higher amount of periprosthetic regurgitation correlated significantly with decreased survival in a multivariate model.

"TAVI is a new therapeutic option for high-risk patients with severe aortic stenosis," the authors write. "Further progress in patient-selection criteria, postprocedural care, and choice of optimal access are essential for improving results."

The study was funded by Edwards Lifesciences and Medtronic; several authors disclosed financial ties to these and other medical device companies.

Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events